Dekel Gelbman joins as SVP, Business Development & Strategy, Robin Patel, M.D. joins DZD's clinical and scientific advisory board and Sally Hojvat, Ph.D. joins as a regulatory strategy advisor
Read More
Initial results show new class of diagnostics can provide culture-free pathogen identification and drug-resistance profile within hours, not days
Read More
Company now occupies over 9,000 square feet of cutting-edge office and lab space
Read More
DZD technical expertise enables identification of novel mechanisms of antibiotic resistance using nanopore sequencing
Read More
CARB-X selects Day Zero Diagnostics for their global portfolio of technologies to combat antibiotic-resistance
Read More
Research published in Infection Control and Hospital Epidemiology details use of patient and environmental whole genome sequencing to stop a CRAB outbreak
Read More